Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Irritable Bowel Syndrome01:23

Irritable Bowel Syndrome

DefinitionIrritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by recurrent combinations of abdominal pain, bloating, diarrhea, or constipation.Pathophysiology of irritable bowel syndromeIts pathophysiology is multifactorial, involving disturbances in motility, sensory processing, microbial balance, barrier integrity, and gut–brain communication. These mechanisms interact to produce symptoms that vary across IBS subtypes.Altered Motility PatternsDisordered...
Gut-Brain Axis01:22

Gut-Brain Axis

The gut–brain axis is a bidirectional communication system that connects the gastrointestinal tract and the brain. This interaction is mediated through multiple pathways, including the vagus nerve, hormonal signals, immune responses, and chemical messengers produced by gut microbes.Microbial Contributions to Brain FunctionGut microbiota contributes significantly to brain function by producing neuroactive compounds. These include neuroactive compounds that influence neurotransmitters such as...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Role of phytotherapeutics in diagnosis and treatment of diabetes

Postepy biochemii·2026
Same author

Tryptophan-Serotonin-Melatonin Pathway as a Contributor to Changes in Mood and Cognitive Functions Induced by Sleep Deprivation.

International journal of molecular sciences·2026
Same author

Evaluation of the Anti-Inflammatory Activity of Selected Plant Extracts in an In Vitro Model of Inflammation Using LPS-Stimulated Macrophages.

Biomedicines·2026
Same author

Gut-Brain Signaling in Parkinson's Disease: A Narrative Review.

International journal of molecular sciences·2026
Same author

Diagnostic Potential of Exosomes in Colorectal Cancer: Current Advances and Future Perspectives.

Molecules (Basel, Switzerland)·2026
Same author

Pancreatic cancer: emerging small molecule pharmacotherapies.

Expert opinion on pharmacotherapy·2026

Related Experiment Video

Updated: May 20, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis
08:40

Chronic Salmonella Infection Induced Intestinal Fibrosis

Published on: September 22, 2019

Brain-Gut Interactions in IBS.

Jakub Fichna1, Martin A Storr

  • 1Department of Biomolecular Chemistry, Faculty of Medicine, Medical University of Lodz Lodz, Poland.

Frontiers in Pharmacology
|July 12, 2012
PubMed
Summary

Irritable bowel syndrome (IBS) is a common disorder lacking clear biomarkers. This review explores the brain-gut axis (BGA) involvement in IBS and potential new therapies.

Area of Science:

  • Gastroenterology
  • Neuroscience
  • Psychiatry

Background:

  • Irritable bowel syndrome (IBS) affects 10-20% of the population.
  • IBS pathophysiology is poorly understood due to absent biomarkers and clear abnormalities.
  • Contributing factors include physical stressors, psychological elements, and environmental influences.

Purpose of the Study:

  • To review current knowledge on the brain-gut axis (BGA) in IBS.
  • To discuss potential future therapeutic strategies for IBS.

Main Methods:

  • Literature review of studies investigating the BGA in IBS.
  • Analysis of potential mechanisms linking the BGA to IBS symptoms.

Main Results:

  • The brain-gut axis (BGA) is implicated in IBS development and symptoms.
Keywords:
autonomic nervous systembrain-gut axishypothalamo-pituitary-adrenal axisirritable bowel syndromepathophysiology

More Related Videos

An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota
07:15

An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota

Published on: July 31, 2019

Related Experiment Videos

Last Updated: May 20, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis
08:40

Chronic Salmonella Infection Induced Intestinal Fibrosis

Published on: September 22, 2019

An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota
07:15

An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota

Published on: July 31, 2019

  • Various stressors and psychological factors may influence the BGA in IBS.
  • Conclusions:

    • The BGA plays a significant role in IBS.
    • Further research into the BGA may lead to novel IBS therapies.